UA109529C2 - COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS - Google Patents

COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS

Info

Publication number
UA109529C2
UA109529C2 UAA201114054A UAA201114054A UA109529C2 UA 109529 C2 UA109529 C2 UA 109529C2 UA A201114054 A UAA201114054 A UA A201114054A UA A201114054 A UAA201114054 A UA A201114054A UA 109529 C2 UA109529 C2 UA 109529C2
Authority
UA
Ukraine
Prior art keywords
particles
suspension
compositions
systems
active agents
Prior art date
Application number
UAA201114054A
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/036650 external-priority patent/WO2010138862A2/en
Publication of UA109529C2 publication Critical patent/UA109529C2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Винахід стосується спільної суспензії, яка може бути доставлена з інгалятора з відміряними дозами, що включає: суспензійне середовище, яке включає фармацевтично прийнятний ГФА пропелент; множину частинок активного агента, вибраного з комбінації формотеролу і будеcоніду та комбінації глікопіролату, формотеролу та будеcоніду; і множину придатних до вдихання частинок, що суспендуються, які включають сухий фосфоліпідний матеріал у вигляді частинок, який практично нерозчинний у пропеленті, де множина частинок, що суспендуються, включає перфоровані мікроструктури та спільно розміщені частинки активного інгредієнта, незалежно від різниці в плавучості між частинками активного агента і частинками, що суспендуються, в суспензійному середовищі. Винахід також стосується застосування вказаної суспензії у медицині та інгалятору її доставки.The invention relates to a co-suspension that can be delivered from a metered dose inhaler comprising: a suspension medium comprising a pharmaceutically acceptable HFA propellant; a plurality of active agent particles selected from a combination of formoterol and budeconide and a combination of glycopyrrolate, formoterol and budeconide; and a plurality of respirable suspendable particles comprising a dry phospholipid particulate material that is substantially insoluble in propellant, wherein a plurality of suspended particles include perforated microstructures and co-located particles of the active ingredient, regardless of the difference between the particles agent and suspending particles in the suspension medium. The invention also relates to the use of said suspension in medicine and the inhaler of its delivery.

UAA201114054A 2009-05-29 2010-05-28 COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS UA109529C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18256509P 2009-05-29 2009-05-29
PCT/US2010/036650 WO2010138862A2 (en) 2009-05-29 2010-05-28 Compositions for respiratory delivery of active agents and associated methods and systems

Publications (1)

Publication Number Publication Date
UA109529C2 true UA109529C2 (en) 2015-09-10

Family

ID=54772474

Family Applications (3)

Application Number Title Priority Date Filing Date
UAA201114057A UA109531C2 (en) 2009-05-29 2010-05-28 COMPOSITIONS FOR PULMONAL DELIVERY OF MUSCARIN ANTAGONISTS OF DURABLE ACTION AND AGONISTS OF ADRENERGIC RECEPTORS B2 DURABLE ACTION AND COMMUNICATION
UAA201114055A UA109530C2 (en) 2009-05-29 2010-05-28 COMPOSITIONS, METHODS AND SYSTEMS FOR THE DELIVERY OF THE BREATHING PATH OF TWO OR MORE ACTIVE AGENTS
UAA201114054A UA109529C2 (en) 2009-05-29 2010-05-28 COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS

Family Applications Before (2)

Application Number Title Priority Date Filing Date
UAA201114057A UA109531C2 (en) 2009-05-29 2010-05-28 COMPOSITIONS FOR PULMONAL DELIVERY OF MUSCARIN ANTAGONISTS OF DURABLE ACTION AND AGONISTS OF ADRENERGIC RECEPTORS B2 DURABLE ACTION AND COMMUNICATION
UAA201114055A UA109530C2 (en) 2009-05-29 2010-05-28 COMPOSITIONS, METHODS AND SYSTEMS FOR THE DELIVERY OF THE BREATHING PATH OF TWO OR MORE ACTIVE AGENTS

Country Status (2)

Country Link
AR (3) AR121758A2 (en)
UA (3) UA109531C2 (en)

Also Published As

Publication number Publication date
UA109530C2 (en) 2015-09-10
AR122477A2 (en) 2022-09-14
AR121758A2 (en) 2022-07-06
UA109531C2 (en) 2015-09-10
AR122478A2 (en) 2022-09-14

Similar Documents

Publication Publication Date Title
CY1122732T1 (en) COMPOSITIONS FOR RESPIRATORY ADMINISTRATION OF ACTIVE AGENTS AND RELATED METHODS AND SYSTEMS
MX2013013440A (en) Compositions, methods & systems for respiratory delivery of two or more active agents.
CY1120605T1 (en) DRY POWDER PREPARATION INCLUDING A PHOSPHODIESTERATION INHIBITOR
BR122021002471B8 (en) NASAL DRUG DISTRIBUTION DEVICE
UA101653C2 (en) Composition for inhalation comprising aclidinium for the treatment of asthma and chronic obstructive pulmonary disease
IN2014DN08672A (en)
UA101652C2 (en) Composition for inhalation comprising aclidinium for the treatment of asthma and chronic obstructive pulmonary disease
TR201109804A2 (en) Single dose inhalation device.
EA201591869A1 (en) COMPOSITION CONTAINING TO IMPROVE THE STABILITY OF THE MEDICINE FORM AT A LESS THEME OF TWO DRY POWDER RECEIVED BY SPRAY DRYING
GB201118188D0 (en) Manufacture of medicinal aerosol canisters
MD20140131A2 (en) Novel dosage and formulation for inhalation comprising aclidinium
CO6270213A2 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING MONTELUKAST ACID AND A DEPDE-4 UNHIBITOR OR AN INHALED CORTICOESTEROID FOR INHALATION ADMINISTRATION
UA109529C2 (en) COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS
EA200801854A1 (en) NEW COMPOSITIONS
TH125298A (en) Composition for the release of the active substance through inhalation and related methods and systems.
MY171271A (en) Method for preparing metered dose sprayed inhaler for treating respiratory disease
TH125298B (en) Composition for the release of the active substance through inhalation and related methods and systems.
RU2586297C3 (en) COMPOSITIONS, METHODS AND SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
TH151324A (en) Composition, methods and systems for the delivery of two or more respiratory active agents.
AR093601A1 (en) COMPOSITIONS, METHODS AND SYSTEMS FOR RESPIRATORY ADMINISTRATION OF TWO OR MORE ACTIVE AGENTS
TH147847A (en) Composition, methods and systems for the delivery of substances. Two or more respiratory agents.
MX2017004583A (en) Pharmaceutical composition containing budesonide and formoterol.
AR098868A1 (en) PHARMACEUTICAL COMPOSITION IN DRY POWDER FOR INHALATION
CR20130589A (en) COMPOSITIONS, METHODS AND SYSTEMS FOR ADMINISTRATION / RESPIRATORY SUPPLY OF TWO OR MORE ACTIVE AGENTS
ECSP13013082A (en) COMPOSITIONS, METHODS AND SYSTEMS FOR RESPIRATORY ADMINISTRATION OF TWO OR MORE ACTIVE AGENTS